欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2023/001
药品名称
Utrogestan
活性成分
progesterone 200.0 mg
剂型
Vaginal capsule, soft
上市许可持有人
Besins Healthcare Ireland Limited Ireland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
Malta (MT)
Utrogestan Vaginal 200 mg Capsules, soft
Denmark (DK)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Netherlands (NL)
Utrogestan 200 mg, zachte capsules voor vaginaal gebruik
Ireland (IE)
Norway (NO)
Poland (PL)
Utrogestan
Latvia (LV)
Progesterone Besins 200 mg mīkstās vaginālās kapsulas
Lithuania (LT)
-
Estonia (EE)
Hungary (HU)
UTROGESTAN 200 mg lágy hüvelykapszula
Bulgaria (BG)
Czechia (CZ)
Uterogestan
Slovakia (SK)
Slovenia (SI)
Croatia (HR)
Spain (ES)
许可日期
2019/03/05
最近更新日期
2024/03/18
药物ATC编码
G03DA04 progesterone
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
Final PL
Final SPC
|
Final SPC
PAR Summary
|
SE_H_2023_001
PAR
|
SE_H_2023_01
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase